Cargando…
Neuronal Trafficking of the Amyloid Precursor Protein—What Do We Really Know?
Alzheimer’s disease (AD) is the most common type of dementia, contributing to 60–80% of cases. It is a neurodegenerative disease that usually starts symptomless in the first two to three decades and then propagates into a long-term, irreversible disease, resulting in the progressive loss of memory,...
Autores principales: | Lin, Tong, Tjernberg, Lars O., Schedin-Weiss, Sophia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301342/ https://www.ncbi.nlm.nih.gov/pubmed/34356865 http://dx.doi.org/10.3390/biomedicines9070801 |
Ejemplares similares
-
Lack of N-glycosylation increases amyloidogenic processing of the amyloid precursor protein
por: Lin, Tong, et al.
Publicado: (2022) -
The Science of Soy: What Do We Really Know?
por: Barrett, Julia R.
Publicado: (2006) -
Dark matter: what do we really know
por: Tao, C
Publicado: (2013) -
Pyorrhea Alveolaris—What Do We Really Know of It
por: Trueman, W. H.
Publicado: (1897) -
Live Cell FRET Imaging Reveals Amyloid β-Peptide Oligomerization in Hippocampal Neurons
por: Gao, Yang, et al.
Publicado: (2021)